Clinical Trials Directory

Trials / Unknown

UnknownNCT04561323

Diagnosing Acute Onset Insufficient Intestinal Blood Flow (Bowel Ischemia) With a Novel CT Technique Called Dual-energy CT (DECT). This Observational Study Seeks to Evaluate Whether DECT Can Improve the Diagnosis of Bowel Ischemia and How the DECT Findings Correlate With Intraoperative Findings

Dual-energy CT in the Diagnosis of All-Cause Acute Bowel Ischemia

Status
Unknown
Phase
Study type
Observational
Enrollment
44 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the performance of dual-energy CT (DECT) in the diagnosis of acute bowel ischemia (ABI). ABI is a condition characterised by inadequate blood supply to portions of the intestine. ABI is a relatively rare condition, but is associated with a high mortality rate. DECT is an emerging field within radiology. Few reports have reported an increased conspicuity for ABI using DECT compared with conventional CT, which is the current preoperative golden standard. The investigators hypothesize that DECT increases conspicuity of ABI compared with conventional CT and that DECT image findings correlate with the intraoperative findings.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDual-energy CTPatients suspected of acute bowel ischemia will be scanned in the dual-energy CT scanner. The abdominal imaging protocols are predetermined by the Department of Diagnostic Radiology, Righospitalet, Denmark.

Timeline

Start date
2020-11-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2020-09-23
Last updated
2021-03-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04561323. Inclusion in this directory is not an endorsement.

Diagnosing Acute Onset Insufficient Intestinal Blood Flow (Bowel Ischemia) With a Novel CT Technique Called Dual-energy (NCT04561323) · Clinical Trials Directory